March 24, 2020 / 6:08 AM / 12 days ago

BRIEF-Santhera Pharmaceuticals FY Net Result At CHF -19.0 Mln

March 24 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG :

* FY NET REVENUES FROM PRODUCT SALES OF CHF 27.9 MILLION, SLIGHTLY ABOVE GUIDANCE

* FY OPERATING RESULT OF CHF -10.4 MILLION (2018: CHF -51.4 MILLION) AND NET RESULT OF CHF -19.0 MILLION (2018: CHF -54.2 MILLION)

* WILL PROPOSE INCREASE OF AUTHORIZED CAPITAL FROM CHF 3,000,000 TO CHF 5,500,000 AND AN INCREASE OF CONDITIONAL CAPITAL FROM CHF 2,500,000 TO CHF 4,800,000

* CONTINUES TO EXPECT OPINION FROM COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE ON ITS MARKETING AUTHORIZATION APPLICATION FOR PULDYSA BY MID-2020

* NO POSSIBILITY TO ATTEND AGM IN PERSON Source text - bit.ly/3dokEF1 Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below